NEPHROCARE HEALTH SERV L (NEPHROPLUS)

NSE: ₹661.00
BSE: ₹661.30
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Dec 2025 Mar 2026
Revenue from Operations 259.73 265.62
YOY Revenue Growth % - -
Other Income 3.32 11.57
Total Income 263.05 277.18
Total Expenses + 226.69 240.87
Cost of Materials Consumed 58.52 59.63
Employee Benefit Expense 43.10 45.93
Other Expenses 97.24 106.29
Operating Profit 33.04 24.74
OPM % 12.7% 9.3%
Profit Before Tax + 36.36 36.31
Tax Expense 4.12 5.94
Tax % 11.3% 16.4%
Profit After Tax 32.24 30.37
EPS (Basic) 3.43 3.03

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026
Revenue from Operations 998.85
YOY Revenue Growth % -
Other Income 24.51
Total Income 1,023.36
Total Expenses + 922.79
Cost of Materials Consumed 226.79
Employee Benefit Expense 171.79
Other Expenses 373.30
Operating Profit 76.05
OPM % 7.6%
Profit Before Exceptional 100.57
Exceptional Items 0.00
Profit Before Tax + 100.57
Tax Expense 23.73
Tax % 23.6%
Profit After Tax 76.84
EPS (Basic) 8.48

Balance Sheet

Particulars Mar 2026
ASSETS
Non-Current Assets + 631.70
Property, Plant & Equipment 396.19
Capital Work in Progress 5.54
Non-Current Investments 7.14
Goodwill 86.69
Other Intangible Assets 33.63
Current Assets + 839.17
Inventories 33.04
Trade Receivables 316.89
Cash and Cash Equivalents 123.89
Current Investments 170.64
LIABILITIES & EQUITY
Total Equity 1,116.49
Equity Share Capital 20.07
Other Equity 1,096.43
Non-Current Liabilities 54.96
Current Liabilities 299.41
Total Liabilities 354.37

Cash Flow Statement

Particulars Mar 2026
Cash from Operating Activities 232.58
Cash from Investing Activities -410.44
Cash from Financing Activities 157.11
Net Increase/Decrease in Cash -1.93